Diagnos Laboratorium Utama Tbk. vs Merdeka Battery Materials Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Merdeka Battery Materials Tbk. trades at Rp520 (market cap 55.08T, 83.26M 24h volume). The key difference: Merdeka Battery Materials Tbk. is far larger — about 177.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Merdeka Battery Materials Tbk. is more actively traded (83.26M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | MBMA | |
|---|---|---|
Market Cap | 310.75B | 55.08T |
Volume | 963.6K | 83.26M |
Lot | 9.64K | 832.61K |
Turnover | 217.67M | 43.41B |
Average Price | 225.89 | 521.35 |
Value | 217.67M | 43.41B |
Indicative Equilibrium Price | 226 | 520 |
Indicative Equilibrium Volume | 1K | 13.46K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Merdeka Battery Materials Tbk (formerly PT Hamparan Logistik Nusantara) (the “Company”) was established based on Notarial Deed No. 66 of Darmawan Tjoa, S.H., S.E., Notary in Jakarta, dated 20 August 2019. The Company’s immediate parent entity is PT Merdeka Energi Nusantara (formerlyPT Batutua Tambang Abadi) (“MEN”) and its ultimate parent entity is PT Merdeka Copper Gold Tbk (“MDKA”), a company incorporated in Indonesia and listed on the Indonesian Stock Exchange (“IDX”).
Read more on MBMA →